Masimo Co. (NASDAQ:MASI) Shares Bought by Vanguard Group Inc.

Vanguard Group Inc. increased its position in Masimo Co. (NASDAQ:MASI) by 0.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,781,343 shares of the medical equipment provider’s stock after buying an additional 26,473 shares during the period. Vanguard Group Inc. owned about 9.04% of Masimo worth $560,421,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. State of Michigan Retirement System raised its holdings in Masimo by 0.9% in the 4th quarter. State of Michigan Retirement System now owns 10,696 shares of the medical equipment provider’s stock valued at $1,254,000 after acquiring an additional 100 shares during the last quarter. Massmutual Trust Co. FSB ADV lifted its position in Masimo by 140.6% during the fourth quarter. Massmutual Trust Co. FSB ADV now owns 243 shares of the medical equipment provider’s stock worth $28,000 after buying an additional 142 shares during the period. Parallel Advisors LLC boosted its stake in Masimo by 48.3% in the 4th quarter. Parallel Advisors LLC now owns 445 shares of the medical equipment provider’s stock worth $52,000 after buying an additional 145 shares during the last quarter. CWM LLC grew its holdings in Masimo by 13.5% in the 4th quarter. CWM LLC now owns 1,318 shares of the medical equipment provider’s stock valued at $154,000 after buying an additional 157 shares during the period. Finally, Treasurer of the State of North Carolina increased its stake in shares of Masimo by 0.9% during the 4th quarter. Treasurer of the State of North Carolina now owns 19,139 shares of the medical equipment provider’s stock valued at $2,243,000 after acquiring an additional 180 shares during the last quarter. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on MASI shares. Needham & Company LLC restated a “hold” rating on shares of Masimo in a report on Wednesday, May 8th. StockNews.com raised Masimo from a “sell” rating to a “hold” rating in a research report on Friday, March 29th. Wells Fargo & Company upgraded Masimo from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $117.00 to $160.00 in a research note on Monday, March 25th. BTIG Research lifted their price objective on Masimo from $145.00 to $166.00 and gave the company a “buy” rating in a research note on Monday, March 25th. Finally, Stifel Nicolaus raised shares of Masimo from a “hold” rating to a “buy” rating and increased their target price for the stock from $148.00 to $170.00 in a research report on Monday, April 15th. Four research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, Masimo presently has a consensus rating of “Moderate Buy” and a consensus target price of $143.57.

Insider Transactions at Masimo

In other Masimo news, Director Craig B. Reynolds sold 40,000 shares of the firm’s stock in a transaction that occurred on Friday, April 26th. The stock was sold at an average price of $136.17, for a total transaction of $5,446,800.00. Following the completion of the sale, the director now owns 7,406 shares in the company, valued at approximately $1,008,475.02. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 9.70% of the company’s stock.

Masimo Stock Performance

Masimo stock opened at $128.73 on Tuesday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.31 and a current ratio of 2.31. Masimo Co. has a one year low of $75.22 and a one year high of $167.04. The stock’s 50 day moving average price is $129.59 and its 200 day moving average price is $128.52. The firm has a market capitalization of $6.85 billion, a PE ratio of 87.57 and a beta of 1.00.

Masimo (NASDAQ:MASI) last announced its earnings results on Tuesday, May 7th. The medical equipment provider reported $0.77 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.06. Masimo had a net margin of 4.01% and a return on equity of 13.26%. The business had revenue of $492.80 million during the quarter, compared to the consensus estimate of $487.70 million. During the same period in the prior year, the firm earned $0.87 earnings per share. The business’s quarterly revenue was down 12.8% compared to the same quarter last year. As a group, sell-side analysts expect that Masimo Co. will post 3.63 EPS for the current fiscal year.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.